What is the recommended diagnostic and management plan for a patient with an enlarged anteverted uterus, markedly thickened endometrium, and a large, vascular cervical mass extending into the lower uterine cavity as described on ultrasound?

Urgent Tissue Diagnosis via Cervical and Endometrial Biopsy with MRI Staging

This patient requires immediate tissue diagnosis through cervical biopsy of the vascular mass and endometrial sampling, followed by MRI pelvis for staging, as the imaging findings are highly suspicious for cervical malignancy with endometrial extension.

Immediate Diagnostic Workup

Priority 1: Tissue Diagnosis

• Cervical biopsy of the anterior cervical mass is mandatory given the highly vascular (color score 4), large (6.6-7.6 × 5.5 cm) heterogeneous mass with extension into the lower endometrial cavity 1, 2, 1
• Endometrial sampling (office biopsy or D&C) to evaluate the markedly thickened endometrium (29.17 mm) 3, 4
• The combination of cervical mass with endometrial extension creates diagnostic ambiguity between:
  • Primary cervical cancer with endometrial extension (more likely given mass characteristics)
  • Primary endometrial cancer with cervical involvement
  • Synchronous primaries

Priority 2: Staging Imaging

• MRI pelvis with contrast is superior to CT for tumor extension assessment and should include pelvic and abdominal imaging 1, 4
• MRI will define:
  • Depth of cervical stromal invasion
  • Parametrial involvement
  • Myometrial invasion depth
  • Lymph node assessment
  • Local pelvic extension

Additional Baseline Studies

• Complete blood count, renal and liver function tests 1
• Chest imaging (CT preferred) for metastasis assessment 1
• Consider SCC antigen if squamous histology confirmed 1
• CA-125 if endometrial origin suspected 3

Critical Clinical Context

The imaging findings are concerning for advanced disease:

• The cervical mass size (6.6-7.6 cm) exceeds FIGO stage IB1 criteria (>4 cm) 2
• High vascularity (color score 4) suggests aggressive tumor biology
• Extension into lower endometrial cavity indicates at least stage II disease if cervical primary, or stage II if endometrial primary with cervical stromal invasion 2, 4
• The markedly thickened endometrium (29.17 mm) far exceeds any normal threshold and requires tissue diagnosis regardless of bleeding status 5, 6

Management Algorithm Based on Histology

If Cervical Cancer Confirmed:

• Stage IB2 or higher (given >4 cm size): Primary treatment is concurrent chemoradiation with cisplatin-based chemotherapy, NOT primary surgery 1, 2, 1
• Radical hysterectomy with pelvic lymphadenectomy is only appropriate for stage IB1 (≤4 cm) disease 1
• Multidisciplinary planning is mandatory 1

If Endometrial Cancer with Cervical Extension:

• Represents at least stage II disease (cervical stromal invasion) 4
• If surgical candidate: Radical or modified radical hysterectomy with bilateral salpingo-oophorectomy, pelvic lymphadenectomy, and peritoneal washings 4, 7
• Alternative: EBRT and brachytherapy followed by surgery 7
• Radical hysterectomy improves local control compared to simple hysterectomy when cervical stroma involved 7

If Synchronous Primaries:

• Treatment guided by most advanced lesion
• Likely requires combined surgical and radiation approach

Common Pitfalls to Avoid

1. Do NOT delay tissue diagnosis - imaging alone cannot differentiate benign from malignant pathology or determine primary site
2. Do NOT perform simple hysterectomy without tissue diagnosis - if cervical cancer confirmed, this would be inadequate treatment and potentially harmful
3. Do NOT assume endometrial origin based solely on endometrial thickening - the cervical mass characteristics (size, vascularity, location) suggest cervical primary
4. Do NOT rely on office endometrial biopsy alone - blind sampling may miss focal lesions, and the cervical mass requires direct visualization and biopsy 6, 8
5. Cervical stenosis may complicate sampling - hysteroscopy may be needed if office procedures inadequate 6

Urgency Considerations

This workup should be completed within 1-2 weeks maximum. The combination of a large, vascular cervical mass with endometrial extension represents potentially advanced gynecologic malignancy requiring prompt diagnosis and treatment initiation to optimize outcomes. Delays in diagnosis directly impact mortality and morbidity in gynecologic cancers 1, 2.

The patient should be counseled about the high suspicion for malignancy and the need for expedited evaluation. Referral to gynecologic oncology should occur immediately upon tissue confirmation of malignancy 3, 1.